Article Versions Notes

Puri A, Pollard AJ, Schmidt-Mutter C, Lainé F, PrayGod G, Kibuuka H, Barry H, Nicolas J-F, Lelièvre J-D, Sirima SB, et al. Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study. Vaccines. 2024; 12(2):210. https://doi.org/10.3390/vaccines12020210

Puri, Adeep, Andrew J. Pollard, Catherine Schmidt-Mutter, Fabrice Lainé, George PrayGod, Hannah Kibuuka, Houreratou Barry, Jean-François Nicolas, Jean-Daniel Lelièvre, Sodiomon Bienvenu Sirima, and et al. 2024. "Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study" Vaccines 12, no. 2: 210. https://doi.org/10.3390/vaccines12020210

Puri, A., Pollard, A. J., Schmidt-Mutter, C., Lainé, F., PrayGod, G., Kibuuka, H., Barry, H., Nicolas, J.-F., Lelièvre, J.-D., Sirima, S. B., Kamala, B., Manno, D., Watson-Jones, D., Gaddah, A., Keshinro, B., Luhn, K., Robinson, C., & Douoguih, M., on behalf of the EBL4001 Study Group. (2024). Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study. Vaccines, 12(2), 210. https://doi.org/10.3390/vaccines12020210